Last reviewed · How we verify
NCT04532073
Sub-study of the Essen Study Centre for the ENTAiER Trial
NA trial testing Eurythmy Therapy in Elderly Patients in 60 participants. Completed in 7 December 2022.
7 December 2022
Quick facts
| Lead sponsor | Universität Duisburg-Essen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 27 July 2021 |
| Primary completion | 7 December 2022 |
| Estimated completion | 7 December 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Eurythmy Therapy
- Tai Chi
- Standard Care — full drug profile →
Conditions studied
- Elderly Patients — all drugs for Elderly Patients →
- Chronically Ill — all drugs for Chronically Ill →
- Increased Risk of Falling — all drugs for Increased Risk of Falling →
Sponsor
Universität Duisburg-Essen — full company profile →
Who can join
65 and older, any sex, with Elderly Patients or Chronically Ill. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study is a sub-study of the ENTAiER study. The ENTAiER study is a multicenter, randomized, controlled study to evaluate the efficacy and safety of eurythmy therapy and Tai Chi in comparison to standard care in chronically ill older patients with an increased risk of falling. In addition to the main questions of the ENTAiER study, three additional questions are being investigated at the Hospital Essen-Steele: Proteome and telomere analyses as well as qualitative parameters are recorded and examined. The aim is to compare the changes in proteomes, telomeres and qualitative factors under eurythmy therapy, Tai Chi and standard care in chronically ill older patients with an increased risk of falling.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04532073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Elderly Patients
Currently open trials in the same condition.
- NCT07108764 — Intraoperative Infusion of Either Lidocaine or Dexmedetomidine on Regional Cerebral Oxygen Saturation and Postoperative · NA · recruiting
- NCT06768580 — Effect of Oral Melatonin Versus Intraoperative Lidocaine Infusion on Incidence of Postoperative Delirium in Elderly Pati · NA · recruiting
- NCT06677645 — Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Ho · recruiting
- NCT07514936 — Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia · Phase 2 · recruiting
- NCT06413342 — Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma · Phase 2 · recruiting
Other Universität Duisburg-Essen trials
Trials by the same sponsor.
- NCT07273045 — A Comprehensive, Multinational GIST Registry · not yet recruiting
- NCT07255313 — Strengthening Health Literacy in Healthcare Workers Through Mind Body Medicine and Nutrition · NA · recruiting
- NCT05645588 — Pranayama for Posttraumatic Stress Disorder · NA · withdrawn
- NCT06666296 — Sustainable Eating for a Healthy Tomorrow - Effectiveness of Digital Nutrition Workshops to Implement the Planetary Heal · NA · completed
- NCT06204458 — Mild Water-filtered Infrared-A Whole-body Hyperthermia in Patients With Post-COVID Syndrome (HyPoCo) · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04532073 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universität Duisburg-Essen
- Last refreshed: 21 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04532073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing